Potential Benefits: Healthy weight loss Appetite control Balanced glucose levels Reduced cravings Cardio-protection Decreased blood pressure Semaglutide is a once-weekly injection that helps control blood sugar levels in adults with Type 2 Diabetes
Semaglutide takes approximately 45 weeks to be substantially eliminated from the body, and symptom resolution typically begins during this clearance period, though some individuals may require longer for complete recovery
Excess fat, especially around the abdomen, contributes to insulin resistance, elevates blood pressure, and promotes inflammation, all of which strain the body over time
Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist administered as a once-weekly injection that works systemically to reduce appetite and slow gastric emptying
Additionally, many individuals report a reduced appetite and a change in eating habits, such as feeling full faster and a decrease in cravings for unhealthy foods, which contribute to a sustainable health-oriented lifestyle